case_images: PMC6413441_01
case_images: Rapid SCORAD improvement and corticosteroid tapering in regards to Omalizumab therapy
case_images: 12948_2019_109_Fig1_HTML.jpg
case_images: PMC6413441_01_12948_2019_109_Fig1_HTML.jpg
case_images: Fig1
case_images: Unexpectedly, clinical results were observed after just about 2 months of treatment as confirmed by a SCORAD of 1, and a clear improvement of QoL (Fig. 1).
case_images: Patient at T0 and after two months of Omalizumab treatment
case_images: 12948_2019_109_Fig2_HTML.jpg
case_images: PMC6413441_01_12948_2019_109_Fig2_HTML.jpg
case_images: Fig2
case_images: After 1 year of Omalizumab treatment, the patient maintains a good control for both skin and gastrointestinal symptoms (Fig. 2).